The common treatment modality for extensive-stage small cell lung cancer is chemotherapy, which significantly improves survival in these patients. However, the median survival is still poor and usually does not reach 12 months. For a long time, surgery has not played any role in the treatment of small cell lung cancer. In recent years, the operative approach has been accepted as a form of treatment for patients with limited-stage disease. However, in patients with resectable primary carcinoma and solitary metastasis, surgery is not recommended, although it is the standard method of treatment in patients with non-small cell lung cancer and other malignancies. We report the longterm survival of a patient with metastatic small cell lung cancer treated with complete resection of both the primary tumor and the solitary brain metastasis.

No abstract

No abstract

No abstract

No abstract